Sherman Mark Andrew

EVP, Gen. Counsel & SecretaryDolby Laboratories, Inc. (DLB) · full profile →Form 4 · filed Dec 17, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$775K
Net Open-Market Flow
-$775K
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Sell(S)2K$67.26$168K71K
Dec 16, 2025Sell(S)2K$67.17$159K73K
Dec 16, 2025Sell(S)7K$66.58$449K75K
Dec 16, 2025Tax withholding(F)3K$66.62$169K82K
Dec 15, 2025Tax withholding(F)9K$67.54$625K85K
Dec 15, 2025Option exercise(M)6K$094K
Dec 15, 2025Grant(A)26K$088K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 15, 2025Grant(A)13K$013K
Dec 15, 2025Option exercise(M)6K$00
Dec 15, 2025Grant(A)56K$056K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-323425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about DLB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-25-323425"
Ask your agent
Use Arkolith to summarize insider buying and selling at Dolby Laboratories, Inc.
over the last 90 days and cite the filings.